| For: | Yu J, Xu FQ. Clinical efficacy and safety of Guipi decoction combined with escitalopram oxalate tablets in patients with depression. World J Clin Cases 2023; 11(29): 7017-7025 [PMID: 37946779 DOI: 10.12998/wjcc.v11.i29.7017] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i29/7017.htm |
| Number | Citing Articles |
| 1 |
Hardik Rana, Parth Patel, Vaishali Thakkar, Tejal Gandhi, Pranav Shah. Depression patient-friendly formulation containing escitalopram and ascorbic acid: design, optimization, characterization, and in vivo taste assessment. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; 399(9) doi: 10.1007/s00210-026-05190-3
|
| 2 |
Qi Wang, Delong Wang, Yuying Lv, Quan Li. Traditional Chinese Medicine in the Management of Anxiety Disorders: A Narrative Review of Theoretical Foundations, Clinical Applications, and Modern Integrative Approaches. Neuropsychiatric Disease and Treatment 2025; doi: 10.2147/NDT.S535646
|
| 3 |
Ming-Yang Xu, Yi Lu, Guo-Mei Shi, Jun Yao, Chun-Qin Ding, Ru-Juan Zhou. Clinical efficacy and effects on hypothalamic-pituitary-adrenal axis function of proscar combined with selective serotonin reuptake inhibitor in post-stroke depression. World Journal of Psychiatry 2026; 16(1): 112139 doi: 10.5498/wjp.v16.i1.112139
|
| 4 |
Chang Wang, Wen Yan, Huijun Fang, Chongze Zhang, Jiale Song, Xingliang An, Fuyixuan Zheng, Aoxue Wei, Wenbin Li, Liping Chen, Rong Wang. LC-MS/MS multi-component quantification and PCA-based quality evaluation of Guipi decoction freeze-dried powder with candidate marker identification. Analytical Methods 2026; doi: 10.1039/D6AY01049K
|
| 5 |
Min Xu, Xu Zhang, Chernor Sulaiman Bah, Yue Yuan, Yan Wang, Chenjian Zhao, Changke Ma, Zexiang Bao. The impact of self-management ability on oral frailty in older adults with hypertension: the chain mediating role of anxiety and nutritional status. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1796196
|